OCXDUHXZYIQNKH-UHFFFAOYSA-N
C30H36F3N7O4S — CID 139400279
Data last refreshed: (MolForge compound catalog, from PubChem)
About OCXDUHXZYIQNKH-UHFFFAOYSA-N
OCXDUHXZYIQNKH-UHFFFAOYSA-N (PubChem CID 139400279) has the molecular formula C30H36F3N7O4S and a molecular weight of 647.72 g/mol. Its IUPAC name is 12,12,18-trimethyl-2,2-dioxo-8-[3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]-2λ6-thia-3,9,11,18,20-pentazatetracyclo[17.2.2.111,14.05,10]tetracosa-1(21),5(10),6,8,19,22-hexaen-4-one.
Molecular Properties
| Compound Name | OCXDUHXZYIQNKH-UHFFFAOYSA-N |
|---|---|
| PubChem CID | 139400279 |
| Molecular Formula | C30H36F3N7O4S |
| Molecular Weight | 647.72 g/mol |
| Exact Mass | 647.25 |
| IUPAC Name | 12,12,18-trimethyl-2,2-dioxo-8-[3-[2-[1-(trifluoromethyl)cyclopropyl]ethoxy]pyrazol-1-yl]-2λ6-thia-3,9,11,18,20-pentazatetracyclo[17.2.2.111,14.05,10]tetracosa-1(21),5(10),6,8,19,22-hexaen-4-one |
| SMILES | CN1CCCC2CN(c3nc(-n4ccc(OCCC5(C(F)(F)F)CC5)n4)ccc3C(=O)NS(=O)(=O)c3ccc1nc3)C(C)(C)C2 |
| InChI | InChI=1S/C30H36F3N7O4S/c1-28(2)17-20-5-4-14-38(3)23-8-6-21(18-34-23)45(42,43)37-27(41)22-7-9-24(35-26(22)39(28)19-20)40-15-10-25(36-40)44-16-13-29(11-12-29)30(31,32)33/h6-10,15,18,20H,4-5,11-14,16-17,19H2,1-3H3,(H,37,41) |
| InChIKey | OCXDUHXZYIQNKH-UHFFFAOYSA-N |
| XLogP | 4.73 |
| TPSA | 122.55 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 647.72 |
| LogP ≤ 5 | 4.73 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 139400279 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.